Myrophine

From Self-sufficiency
Revision as of 12:01, 13 March 2010 by C6541 (Talk) (clean up and re-categorisation per CFD using AWB)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Myrophine
350px
Systematic (IUPAC) name
7,8-didehydro-4,5α-epoxy-17-methyl-3-(phenylmethoxy)-morphinan-6-ol tetradecanoate
Legal status
Legal status
Identifiers
CAS Number 467-18-5
ATC code none
PubChem CID 635600
Synonyms Myristylbenzylmorphine
Chemical data
Formula C38H51NO4
Molar mass 585.82 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Myrophine (Myristylbenzylmorphine) is an opiate analogue that was developed in 1952. It is a derivative of morphine.

Myrophine is substituted with a 3-benzyl group and a 6-myristyl chain. It is metabolised to form benzylmorphine and then further to morphine, and so is a long-acting prodrug for morphine, but with a slow onset of effects. It is a Schedule I drug in the USA and is controlled under international drug conventions. Myrophine is almost invariably used as the hydrochloride (free base conversion ratio 0.94) and has a DEA Administrative Controlled Substance Control Number of 9308.

References


sv:Myrofin